Prostate cancer biomarkers: Are we hitting the mark?
Purpose: Localised prostate cancer diagnosis and management is increasingly complex due to its heterogeneous progression and prognostic subgroups. Pitfalls in current screening and diagnosis have prompted the search for accurate and invasive molecular and genetic biomarkers for prostate cancer. Such...
Main Authors: | Shannon McGrath, Daniel Christidis, Marlon Perera, Sung Kyu Hong, Todd Manning, Ian Vela, Nathan Lawrentschuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | Prostate International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888216300290 |
Similar Items
-
Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
by: Sonja Cabarkapa, et al.
Published: (2016-12-01) -
Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
by: Daniel Christidis, et al.
Published: (2017-06-01) -
Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?
by: Sonja Cabarkapa, et al.
Published: (2018-03-01) -
Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years
by: Marlon Perera, et al.
Published: (2016-03-01) -
Primary care follow-up of radical prostatectomy patients: A regional New Zealand experience
by: Omid Yassaie, et al.
Published: (2016-12-01)